The APAC MRDR Coordinating Principal Investigator, Professor Andrew Spencer, recently presented an oral presentation at Blood 2025, titled Regional trends in first-line myeloma treatment: Real-world results from the Australian & New Zealand and Asia-Pacific Myeloma and Related Diseases Registry“.

The APAC MRDR Team also presented the research as a poster presentation at the ACTA Symposium in November 2025.